Conversely, the SLC22A17 expression was mainly downregulated in tumor samples showing different regulation mechanisms compared to LCN2 and MMP9. Interestingly, the overall expression profile of these genes in tumors was often system- or organ-specific and dependent on epigenetic mechanisms, thus, identifying specific DNA methylation patterns in TCGA tumors. This evidence concerns the gene LCN2 and neoplasm.